| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.80B | 72.35B | 64.04B | 50.16B | 32.19B | 23.20B |
| Gross Profit | 45.39B | 44.80B | 39.80B | 30.11B | 17.62B | 11.64B |
| EBITDA | 19.10B | 19.10B | 16.83B | 11.42B | 4.10B | 946.60M |
| Net Income | 12.16B | 12.12B | 10.83B | 7.02B | 1.92B | -569.63M |
Balance Sheet | ||||||
| Total Assets | 48.31B | 51.98B | 46.51B | 36.95B | 27.47B | 25.05B |
| Cash, Cash Equivalents and Short-Term Investments | 22.95B | 26.08B | 23.69B | 17.16B | 9.91B | 7.31B |
| Total Debt | 541.00M | 300.00M | 307.02M | 450.69M | 734.00M | 976.33M |
| Total Liabilities | 10.86B | 11.89B | 11.29B | 10.44B | 7.11B | 5.71B |
| Stockholders Equity | 37.45B | 40.09B | 35.22B | 26.52B | 20.36B | 19.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.08B | 8.97B | 8.53B | 3.86B | -505.38M |
| Operating Cash Flow | 0.00 | 13.20B | 10.85B | 9.09B | 4.29B | 82.90M |
| Investing Cash Flow | 0.00 | -3.44B | -2.00B | -1.62B | -526.87M | -605.09M |
| Financing Cash Flow | 0.00 | -7.37B | -2.32B | -1.22B | -1.18B | -462.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥232.47B | 12.35 | 13.33% | 3.47% | 4.21% | 23.86% | |
72 Outperform | ¥78.68B | 6.88 | ― | 1.55% | 5.78% | 14.23% | |
72 Outperform | ¥31.35B | 10.02 | ― | 1.23% | 6.74% | 29.20% | |
66 Neutral | ¥316.68B | 16.40 | ― | 1.70% | 10.55% | 7.33% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | ¥42.44B | 19.93 | ― | 0.60% | 10.46% | ― | |
49 Neutral | ¥63.33B | 14.49 | ― | 1.14% | 8.17% | 10.65% |